Related Experiment Videos

[Validation and comparison of pharmacogenetics-based warfarin dosing algorithms in Han Chinese patients]

Liang-ping Yu1, Hong-tao Song, Zhi-yong Zeng

  • 1Department of Pharmacy, Fuzhou General Hospital of Nanjing Military Region, Fuzhou 350025, China.

Insights

Pharmacogenetics-based warfarin dosing algorithms were evaluated in Han Chinese patients with mechanical heart valves. The Wen model best predicted warfarin doses, while the Ohno model showed superior clinical accuracy for dose adjustments.

Area of Science:

  • Pharmacogenomics
  • Cardiovascular Surgery
  • Internal Medicine

Background:

  • Warfarin dosing requires careful management, especially in patients with mechanical heart valves.
  • Genetic factors, including CYP2C9 and VKORC1 polymorphisms, significantly influence warfarin metabolism and response.
  • Existing pharmacogenetic algorithms aim to personalize warfarin dosing but require validation in diverse populations.

Purpose of the Study:

  • To evaluate the predictive accuracy of three established pharmacogenetics-based warfarin dosing algorithms.
  • To determine the most suitable algorithm for estimating the maintenance warfarin dose in Han Chinese patients who have undergone mechanical heart valve replacement.

Main Methods:

  • Genotyping for CYP2C9 and VKORC1 polymorphisms using PCR-RFLP in 130 Han Chinese patients.
  • Calculation of predicted warfarin doses using the IWPC, Ohno, and Wen algorithms.
  • Assessment of prediction accuracy using absolute and percentage differences, R-squared values, and clinical dosing categories (under-, ideally-, and over-dosed).

Main Results:

  • The Wen model demonstrated the lowest average absolute error (3.74 mg/wk) and highest R-squared (40.2%).
  • The Wen model achieved the best prediction accuracy in the low-dose group (50.0% ideally dosed).
  • The Ohno model showed the highest clinical accuracy in the middle-dose group (85.29% ideally dosed).

Conclusions:

  • The Wen algorithm provides the best overall accuracy for predicting maintenance warfarin doses in this patient cohort.
  • The Ohno algorithm offers superior clinical accuracy for dose adjustments in the middle-dose range.
  • Algorithm selection may depend on the specific accuracy metric and patient dosing group considered.
Abstract

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...